DRTS
DRTS
Alpha Tau Medical LtdOUTPERFORM
Company Information
SectorHealthcare
IndustryBiotechnology
Market Cap$1.32B
Analysts Rating2.2/5
Recommendation Details
PortfolioSmallcap
DateSep 4, 2026
ForecastQ Daily Probabilities
72.9%
50.1%
48.0%
Smallcap holds up to 12 names drawn from Small caps above $200M at $1+ share price. Small caps at or above their analyst target across a 12-slot book. No maximum hold, each position carries a 25% stop-loss. Benchmark: Russell 2000.
Company Description
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.